Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Kiebish MA, Tekumalla P, Ravipaty S, Dobi A, Srivastava S, Wu W, Patil S, Friss T, Klotz A, Srinivasan A, Cullen J, Rosner IL, Ali A, Laszlo S, Petrovic M, Fleshner N, Garren J, Miller G, Mahaveer Chand N, Rodrigues LO, Granger E, Kellogg MD, Luan S, Diamandis E, Akmaev VR, Sarangarajan R, Bountra C, Freedland SJ, McLeod DG, Narain NR (2021) Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia. Sci Rep 11(1):15052

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butler SS, Muralidhar V, Zhao SG, Sanford NN, Franco I, Fullerton ZH, Chavez J, D’Amico AV, Feng FY, Rebbeck TR, Nguyen PL, Mahal BA (2020) Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF grade D recommendations against prostate-specific antigen screening in 2012. Cancer 126(4):717–724

Article  CAS  PubMed  Google Scholar 

Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA (2020) MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med 382(10):917–928

Article  PubMed  PubMed Central  Google Scholar 

Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822

Article  PubMed  Google Scholar 

Pagniez MA, Kasivisvanathan V, Puech P, Drumez E, Villers A, Olivier J (2020) Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: a systematic review and meta-analysis. J Urol 204(1):24–32

Article  CAS  PubMed  Google Scholar 

Annamalai A, Fustok JN, Beltran-Perez J, Rashad AT, Krane LS, Triche BL (2022) Interobserver agreement and accuracy in interpreting mpMRI of the prostate: a systematic review. Curr Urol Rep 23(1):1–10

Article  PubMed  Google Scholar 

Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2018) What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology 286(1):186–195

Article  PubMed  Google Scholar 

Zhang J, Xu L, Zhang G, Zhang X, Bai X, Sun H, Jin Z (2023) Effects of dynamic contrast enhancement on transition zone prostate cancer in prostate imaging reporting and data system version 2.1. Radiol Oncol

Salib A, Halpern E, Eisenbrey J, Chandrasekar T, Chung PH, Forsberg F, Trabulsi EJ (2022) The evolving role of contrast-enhanced ultrasound in urology: a review. World J Urol

Yang G, Ruan L (2022) Imaging findings of prostate tuberculosis by transrectal contrast-enhanced ultrasound and comparison with 2D ultrasound and pathology. Br J Radiol 95(1129):20210713

Article  PubMed  Google Scholar 

Jung EM, Wertheimer T, Putz FJ, Jung F, Kammerer S, Pregler B, Luerken L, Stroszczynski C, Beyer L (2020) Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia. Clin Hemorheol Microcirc 76(2):143–153

Article  CAS  PubMed  Google Scholar 

Wink M, Frauscher F, Cosgrove D, Chapelon JY, Palwein L, Mitterberger M, Harvey C, Rouvière O, de la Rosette J, Wijkstra H (2008) Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 54(5):982–992

Article  PubMed  Google Scholar 

Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert DA, Cosgrove D, Deganello A, D’Onofrio M, Drudi FM, Freeman S, Harvey C, Jenssen C, Jung EM, Klauser AS, Lassau N, Meloni MF, Leen E, Nicolau C, Nolsoe C, Piscaglia F, Prada F, Prosch H, Radzina M, Savelli L, Weskott HP, Wijkstra H (2018) The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Long Version). Ultraschall Med 39(2):e2–e44

Article  PubMed  Google Scholar 

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340–351

Article  PubMed  Google Scholar 

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252

Article  PubMed  Google Scholar 

Sano F, Terao H, Kawahara T, Miyoshi Y, Sasaki T, Noguchi K, Kubota Y, Uemura H (2011) Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int 107(9):1404–1410

Article  PubMed  Google Scholar 

Wildeboer RR, Mannaerts CK, van Sloun RJG, Budäus L, Tilki D, Wijkstra H, Salomon G, Mischi M (2020) Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics. Eur Radiol 30(2):806–815

Article  PubMed  Google Scholar 

Liu G, Wu S, Huang L (2020) Contrast-enhanced ultrasound evaluation of the prostate before transrectal ultrasound-guided biopsy can improve diagnostic sensitivity: a STARD-compliant article. Medicine 99(19):e19946

Article  PubMed  PubMed Central  Google Scholar 

Grey ADR, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F, Patki P, Shah TT, Hamid S, Ghei M, Gilbert K, Campbell D, Brew-Graves C, Arumainayagam N, Chapman A, McLeavy L, Karatziou A, Alsaadi Z, Collins T, Freeman A, Eldred-Evans D, Bertoncelli-Tanaka M, Tam H, Ramachandran N, Madaan S, Winkler M, Arya M, Emberton M, Ahmed HU (2022) Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study. Lancet Oncol 23(3):428–438

Article  PubMed  Google Scholar 

Kunz P, Kiesl S, Groß S, Kauczor HU, Schmidmaier G, Fischer C (2020) Intra-observer and device-dependent inter-observer reliability of contrast-enhanced ultrasound for muscle perfusion quantification. Ultrasound Med Biol 46(2):275–285

Article  PubMed  Google Scholar 

Postema AW, Frinking PJ, Smeenge M, De Reijke TM, De la Rosette JJ, Tranquart F, Wijkstra H (2016) Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer. BJU Int 117(4):598–603

Article  PubMed  Google Scholar 

Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S (2016) PI-RADS prostate imaging-reporting and data system: 2015, Version 2. Eur Urol 69(1):16–40

Article  PubMed  Google Scholar 

Pang X, Zhang J, Chen L, Yuan Y, Xu D (2022) Study on the diagnostic value of contrast-enhanced ultrasound and magnetic resonance imaging in prostate cancer. Evid Based Complement Alternat Med 2022:7983530

Article  PubMed  PubMed Central  Google Scholar 

Sato T, Isoda H, Fujimoto K, Furuta A, Fujimoto M, Ito K, Kobayashi T, Nakamoto Y (2021) Evaluation of weighted diffusion subtraction for detection of clinically significant prostate cancer. J Magn Reson Imag 54(6):1979–1988

Article  Google Scholar 

Maxeiner A, Fischer T, Schwabe J, Baur ADJ, Stephan C, Peters R, Slowinski T, von Laffert M, Marticorena Garcia SR, Hamm B, Jung EM (2019) Contrast-enhanced ultrasound (CEUS) and quantitative perfusion analysis in patients with suspicion for prostate cancer. Ultraschall Med 40(3):340–348

Article  PubMed  Google Scholar 

Jung EM, Wiggermann P, Greis C, Eder F, Ehrich J, Jung W, Schreyer AG, Stroszczynski C, Ganzer R (2012) First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results. Clin Hemorheol Microcirc 52(2–4):167–177

Article  CAS  PubMed  Google Scholar